SAFE-D study: blood test for early pancreatic cancer in new type 2 diabetes

Practices are invited to join a study of the Avantect blood test in people recently diagnosed with type 2 diabetes. It starts mid-September in the West Midlands.

In brief: Practices are invited to join a study of the Avantect blood test in people recently diagnosed with type 2 diabetes. It starts mid-September in the West Midlands.

🔒 For Birmingham LMC member practices

The full text of this ICB brief item is available to GPs and staff in Birmingham practices. Log in to read it, or get access with your nhs.net email.

Log inGet access